Early test for enlarged prostate drug begins in healthy men
NCT ID NCT07103278
Summary
This early-stage study aims to compare the safety and how the body processes two different versions of a drug being developed for an enlarged prostate (BPH). It will involve 44 healthy adult male volunteers. The main goal is to see how much of each drug version gets into the bloodstream and how long it stays there.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.